Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds 2014-3-12 2014-7-31
Hydrochloride salts of an antibiotic compound 2014-3-06 2015-12-02
Neprilysin inhibitors 2014-3-04 2015-11-04
Quaternary ammonium diphenylmethyl compound useful as muscarinic receptor … 2014-2-25 2014-5-29
Neprilysin inhibitors 2013-8-07 2015-4-15
Dual-acting antihypertensive agent 2013-6-19 2013-10-31
Neprilysin inhibitors 2013-6-06 2015-3-25
Crystalline form of 8-azabicyclo[3.2.1]octane compound 2013-5-10 2013-8-08
Hepatitis c virus inhibitors 2013-4-24 2015-1-21
Piperazine-piperidine compounds as hepatitis C virus inhibitors 2013-4-24 2015-1-21
Cross-linked glycopeptide-cephalosporin antibiotics 2012-11-16 2013-3-07
8-AZABICYCLO[3.2.1]OCTANE COMPOUND AS μ OPIOID RECEPTOR ANTAGONIST 2012-8-01 2012-11-01
Benzimidazole-carboxamide compound as 5-ht4 receptor agonist 2012-7-23 2012-10-18
Crystalline form of quinolinone-carboxamide compound 2012-5-17 2012-8-16
Crystalline form of biphenyl compound 2012-3-22 2012-6-28
Crystalline form of biphenyl compound 2012-3-05 2012-6-07
Neprilysin inhibitors 2011-12-14 2015-11-18
Phosphonate derivatives of a glycopeptide. 2011-11-30 2012-3-15
Crystalline oxalate salts of a diamide compound 2011-9-29 2013-6-05
BIPHENYL DERIVATIVE HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC … 2011-8-05 2011-11-10
Biphenyl compound useful as muscarinic receptor antagonist 2011-8-04 2011-11-04
Compound having beta 2 adrenergic receptor agonist activity and muscarinic … 2011-5-30 2011-9-29
Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents 2011-1-18 2012-11-28
1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and … 2011-1-10 2012-11-21
DIARYLMETHYL COMPOUND AND RELATED COMPOUND HAVING β2 ADRENERGIC RECEPTOR … 2010-10-15 2011-1-27
Use of echinocandin antifungal agent in combination with glycopeptide … 2010-10-07 2011-1-06
Hydrochloride salts of glycopeptide phosphonate derivative 2010-8-24 2011-1-27
Use of polyene macrolide antifungal agent in combination with glycopeptide … 2010-7-27 2010-10-28
Oncokinase fusion polypeptide associated with hyperproliferative and related … 2010-7-23 2010-12-16
3-phenoxymethylpyrrolidine compounds 2010-7-14 2014-9-17 2014-9-17
Oxazole-based double-acting antihypertensive agents 2010-7-14 2014-2-04 2014-2-04
3-phenoxymethylpyrrolidine compounds 2010-7-12 2016-1-20
Crosslinked glycopeptide-cephalosporin antibiotic 2010-6-07 2010-11-11
Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic … 2010-4-16 2012-2-29
5-HT4 receptor agonist compounds for treatment of cognitive disorders 2010-4-12 2016-8-10
Substituted 4-amino-1-(pyridylmethyl)piperidine as muscarinic receptor … 2009-12-16 2010-3-18
Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid 2009-9-29 2010-4-08
Compounds of 3- (phenoxyphenylmethyl) pyrrolidine 2009-7-23 2013-12-16 2013-12-16
Dual-acting antihypertensive agents 2009-7-23 2011-6-22
Cross-linked glycopeptide-cephalosporin antibiotic 2009-6-17 2009-11-05
Dual-acting antihypertensive agents 2009-4-28 2011-3-23
2 -aminotetralin derivatives as mu opioid receptor antagonists 2009-3-31 2011-2-09
Cross-linked glycopeptide-cephalosporin antibiotic 2009-3-23 2009-7-02
ARYL ANILINE beta2 ADRENERGIC RECEPTOR AGONIST 2009-3-16 2009-7-30
Amidine-containing compounds useful as muscarinic receptor antagonists 2008-12-12 2010-9-01
Aminotetralin compounds as opioid receptor antagonists mu 2008-12-10 2013-5-08 2013-5-08
3-carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists 2008-12-10 2010-9-29
Dual-acting benzoimidazole derivative and their use as antihypertensive agents 2008-12-08 2012-4-25 2012-4-25
COMPOUNDS CONTAINING GUANIDINE, USEFUL AS ANTAGONISTS OF THE MUSCAR�? NICO … 2008-9-05 2012-3-01 2012-3-01
Dual-acting antihypertensive agents 2008-9-05 2010-6-30
DISUBSTITUTED ALKYL-8-AZABICYCLOÄ3.2.1ÜOKTAN COMPOUNDS AS MU OPIOID RECEPTOR … 2008-8-26 2011-5-05
Heteroaryl-8-azabicyclo [3.2.1] octane compounds, as antagonists of the opioid … 2008-8-26 2014-6-06 2014-6-06
Compounds of 8-azabicyclo [3.2.1] octyl-2-hydroxybenzamide as opioid receptor … 2008-8-26 2014-4-11 2014-4-11
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor … 2008-8-26 2010-5-19
Double acting benzoimidazole antihypertensive agent 2008-6-04 2013-4-23 2013-4-23
Prokinetic agent for bowel preparation 2008-5-15 2008-11-20
Short-acting sedative hypnotic agent for anesthesia and sedation 2008-5-13 2008-11-27
Quaternary ammonium compounds useful as muscarinic receptor antagonists 2008-4-23 2013-7-17 2013-7-17
Reductive alkylation process on glycopeptide 2008-4-03 2008-9-25
Glycopeptide antibiotic composition containing cyclodextrin 2008-4-03 2008-10-02
Quinolinone-carboxamide compound as 5-ht4 receptor agonist 2008-3-24 2008-7-31
Method for preparing glycopeptide phosphonate derivative 2008-3-13 2008-9-11
Dual-acting antihypertensive agents 2008-1-31 2009-12-16
Crystalline forms of a dimethylphenyl compound 2007-4-24 2007-11-08
Dialkylphenyl compounds that have beta2-adrenergic receptor agonist activity … 2007-4-24 2012-11-28 2012-11-28
CRYSTAL FORMS OF A DIMETHYLPHENYL COMPOUND. 2007-4-24 2012-1-02 2012-1-02
8-AZABICICLO COMPOUNDS [3.2.1] OCTANO AS ANTAGONISTS OF OPIOID RECEPTORS MU. 2007-2-28 2011-10-14 2011-10-14
Process for preparing 8-azabicylo[3.2.1]octan-3-one intermediates to 5-ht4 … 2007-2-15 2007-8-30
Carbamate compounds as 5-ht4 receptor agonists 2006-11-21 2008-8-27
Biphenyl compounds useful as muscarinic receptor antagonists 2006-6-12 2008-3-05
Benzoimidazolone-carboxamide compounds as 5-ht4 receptor agonists 2006-6-06 2008-3-26
Biphenyl compounds useful as muscarinic receptor antagonists 2006-3-09 2007-11-21
Biphenyl compounds useful as muscarinic receptor antagonists 2006-3-09 2007-11-21
Biphenyl compounds useful as muscarinic receptor antagonists 2006-3-09 2007-12-19
Crystalline forms of a biphenyl compound 2006-3-09 2006-9-14
Biphenyl compounds useful as muscarinic receptor antagonists 2006-3-09 2007-11-21
Quinolinone compounds as 5-ht4 receptor agonists 2006-3-01 2008-4-16
Crystalline form of an indazole-carboxamide compound 2006-2-16 2007-10-31
Indazole-carboxamide compounds 2005-12-21 2006-6-29
Quinolinone-carboxamide compounds 2005-11-04 2007-7-18
5-ht4 receptor agonist compounds 2005-11-04 2007-7-18
Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and … 2005-10-27 2007-7-11
Amidine substituted aryl aniline compounds 2005-9-08 2007-5-23
Diaryl ether beta2 adrenergic receptor agonists 2005-7-20 2007-5-02
Diamine beta2 adrenergic receptor agonists 2005-6-02 2005-12-22
Biphenyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-22
Diphenylmethyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-29
Biphenyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-22
Biphenyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-22
Biphenyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-22
USEFUL BIFENYL COMPOUNDS AS ANTAGONISTS OF THE MUSCARINIC RECEIVER. 2005-3-10 2008-11-01 2008-11-01
Biphenyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-22
Biphenyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-22
Biphenyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-22
Diphenylmethyl compounds useful as muscarinic receptor antagonists 2005-3-10 2006-11-22
Indazole-carboxamide compounds as 5-HT4 receptor agonists 2005-2-17 2005-9-01
Aryl aniline derivatives as beta2 adrenergic receptor agonists 2005-1-11 2005-8-04
Compositions for use in the treatment of mutant receptor tyrosine kinase driven … 2004-12-09 2006-9-13
Naphthalene-1,5-disulfonic acid salts of a substituted 4-amino-1-(pyridylmethyl … 2004-10-28 2006-7-19
AGENTS ETILAMINO AMINO REPLACED BY THE BETA2 ADRENERGIC RECEIVER. 2004-9-21 2009-10-02 2009-10-02